Global Ocular Implants Market - Industry Trends and Forecast to 2028

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Ocular Implants Market - Industry Trends and Forecast to 2028

  • Medical Devices
  • Aug 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Ocular Implants Market

Market Size in USD Million

CAGR :  % Diagram

Bar chart comparing the Global Ocular Implants Market size in 2020 - 8662.29 and 2028 - 13743.99, highlighting the projected market growth. USD 8,662.29 Million USD 13,743.99 Million 2020 2028
Diagram Forecast Period
2021 –2028
Diagram Market Size (Base Year)
USD 8,662.29 Million
Diagram Market Size (Forecast Year)
USD 13,743.99 Million
Diagram CAGR
%
Diagram Major Markets Players
  • areBausch &amp
  • Lomb Incorporated
  • Zeiss International
  • Johnson &amp
  • Johnson Private Limited

Global Ocular Implants Market, By Type (Intraocular Lenses, Ocular Prosthesis, Glaucoma Implants, Corneal Implants, Orbital implants, Others), Application (Glaucoma Surgery, Ocuplasty, Drug Delivery, Age-Related Macular Degeneration, Aesthetic Purpose, Others), Material (Non-integrated Implants, Integrated Implants), End User (Eye Specialty Clinics, Eye Institutes, Ambulatory surgical centers, Specialty clinics, Hospitals, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Ocular Implants Market

Market Analysis and Insights of Global Ocular Implants Market

Global ocular implants market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 8,662.29 million in 2020 to USD 13,743.99 by 2028 growing at a CAGR of 5.94% in the above-mentioned forecast period.

Ocular implants are basically the surgically implanted artificial devices to replace the damaged tissue which treats eye diseases/disorders and restore the sharpness of vision. The artificial devices are highly suited for the eyes.

The surging cases of resbyopia, near sightedness, blindness, cataract surgeries and farsightedness is expected to trigger the demands for global ocular implants market. Other impactful reasons for the growth of market are increasing awareness related to the eye care, surging geriatric populations and rise in healthcare expenditure. However, the dearth of the skilled physician or professional is expected to restraint growth of the market in developing regions. The increasing research and development especially in the ocular implants is projected to generate new lucrative growth opportunities within the forecast period for the market. The difficulties associated with implantation and post- implantation and the side effects of the ocular implants might prove as a major challenge for the market growth.

This ocular implants  market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research ocular implants market contact us for an Analyst Brief our team will help you take an informed market decision to achieve market growth.

Global Ocular Implants Market Scope and Market Size

Ocular implants market is segmented on the basis of type, application, material and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on type, the ocular implants market is segmented into intraocular lenses, ocular prosthesis, glaucoma implants, corneal implants, orbital implants and others.
  • On the basis of application, the ocular implants market is segmented into glaucoma surgery, ocuplasty, drug delivery, age-related macular degeneration, aesthetic purpose and others.
  • On the basis of material, the ocular implants market is segmented into non-integrated implants and integrated implants. Non-integrated are further segmented into acrylic, glass and silicon. The integrated implants are also further segmented into aluminium oxide, hydroxyapatite and others.
  • On the basis of end user, the ocular implants market is bifurcated into eye specialty clinics, eye institutes, ambulatory surgical centers, specialty clinics, hospitals and others..

Ocular Implants Market Country Level Analysis

Ocular implants market is analysed and market size insights and trends are provided by type, application, material and end user as referenced above.

The countries covered in the ocular implants  market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

 North America is projected to dominate the ocular implants market due to increasing geriatric population and the availability of reimbursement facilities. On the other hand, Asia-Pacific is anticipated to have a fastest growth rate in the forecast period of 2021 to 2028 due to the rapidly increasing expenditure on eye care by individuals and government and rising population.

The country section of the ocular implants market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Ocular implants market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for ocular implants market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ocular implants  market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Global Ocular Implants MarketShare Analysis

Ocular implants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to ocular implants market.

 The major players covered in the ocular implants market report are Bausch & Lomb Incorporated, Zeiss International, Johnson & Johnson Private Limited, MORCHER, STAAR SURGICAL, HOYA Corporation, AST Products, Inc., Second Sight, Allergan, Lubrizol Life Science, SMR Ophthalmic Pvt. Ltd., MED-EL Medical Electronics., MeKo Laser Material Processing, NVISION Eye Centers, iSTARMedica,, Gulden Ophthalmics, Ophtec BV, Aetna Inc., and Care Group, among other domestic and global players. Market data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL OCULAR IMPLANTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL OCULAR IMPLANTS MARKET

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 MARKET GUIDE

2.2.4 MULTIVARIATE MODELLING

2.2.5 TOP TO BOTTOM ANALYSIS

2.2.6 STANDARDS OF MEASUREMENT

2.2.7 VENDOR SHARE ANALYSIS

2.2.8 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.9 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL OCULAR IMPLANTS MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

5.3 VALUE CHAIN ANALYSIS

5.4 STRENGHT OF PRODUCT PORTFOLIO

5.5 BUSINESS STRATEGY EXCELLENCE

5.6 CASE STUDIES

5.7 TECHNOLOGICAL TRENDS

5.8 PRICING ANALYSIS

5.9 SUPPLY CHAIN ANALYSIS

6 INDUSTRY INSIGHTS

7 REGULATORY FRAMEWORK

8 GLOBAL OCULAR IMPLANTS MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 INTRAOCULAR LENSES (IOLS)

8.2.1 BY FUNCTIONALITY

8.2.1.1. MONOFOCAL IOLS

8.2.1.2. MULTIFOCAL IOLS

8.2.1.3. TORIC IOLS

8.2.1.4. ACCOMMODATIVE IOLS

8.2.1.5. OTHERS

8.2.2 BY MATERIAL

8.2.2.1. PMMA IOLS

8.2.2.2. FOLDABLE ACRYLIC IOLS (HYDROPHOBIC & HYDROPHILIC)

8.2.2.3. SILICONE IOLS

8.2.3 BY DESIGN

8.2.3.1. ANTERIOR CHAMBER IOLS

8.2.3.2. POSTERIOR CHAMBER IOLS

8.2.3.3. PHAKIC IOLS

8.3 CORNEAL IMPLANTS

8.3.1 BY TYPE

8.3.1.1. SYNTHETIC CORNEAL IMPLANTS

8.3.1.2. BIOLOGICAL CORNEAL IMPLANTS

8.3.2 BY INDICATION

8.3.2.1. KERATOCONUS

8.3.2.2. CORNEAL SCARRING

8.3.2.3. FUCHS' DYSTROPHY

8.3.2.4. OTHER

8.4 ORBITAL IMPLANTS

8.4.1 POROUS ORBITAL IMPLANTS

8.4.2 NON-POROUS ORBITAL IMPLANTS

8.5 GLAUCOMA IMPLANTS

8.5.1 BY TYPE

8.5.1.1. AQUEOUS SHUNT DEVICES

8.5.1.2. MICROINVASIVE GLAUCOMA SURGERY (MIGS) IMPLANTS

8.5.1.3. OTHERS

8.5.2 BY MATERIAL

8.5.2.1. SILICONE

8.5.2.2. POLYPROPYLENE

8.6 OCULAR PROSTHETICS (ARTIFICIAL EYE IMPLANTS)

8.6.1 BY TYPE

8.6.1.1. STOCK PROSTHETIC EYES

8.6.1.2. CUSTOM PROSTHETIC EYES

8.6.2 BY MATERIAL

8.6.2.1. PMMA

8.6.2.2. GLASS-BASED PROSTHETICS

8.7 OTHERS

9 GLOBAL OCULAR IMPLANTS MARKET, BY MATERIAL

9.1 OVERVIEW

9.2 POLYMETHYL METHACRYLATE (PMMA)

9.3 HYDROPHOBIC ACRYLIC

9.4 HYDROPHILIC ACRYLIC

9.5 SILICONE

9.6 HYDROGEL

9.7 COLLAGEN-BASED BIOMATERIALS

9.8 POLYETHYLENE

9.9 OTEHRS

10 GLOBAL OCULAR IMPLANTS MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 GLAUCOMA SURGERY

10.3 OCUPLASTY, DRUG DELIVERY

10.4 AGE-RELATED MACULAR DEGENERATION

10.5 AESTHETIC PURPOSE

10.6 OTHERS

11 GLOBAL OCULAR IMPLANTS MARKET, BY END-USER

11.1 OVERVIEW

11.2 EYE SPECIALTY CLINICS

11.3 EYE INSTITUTES

11.4 AMBULATORY SURGICAL CENTERS

11.5 SPECIALTY CLINICS

11.6 HOSPITALS

11.7 OTHERS

12 GLOBAL OCULAR IMPLANTS MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

12.3.1 ONLINE

12.3.2 OFFLINE

12.4 OTHER

13 GLOBAL OCULAR IMPLANTS MARKET, BY REGION

GLOBAL OCULAR IMPLANTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

13.2 EUROPE

13.2.1 GERMANY

13.2.2 U.K.

13.2.3 ITALY

13.2.4 FRANCE

13.2.5 SPAIN

13.2.6 RUSSIA

13.2.7 SWITZERLAND

13.2.8 TURKEY

13.2.9 BELGIUM

13.2.10 NETHERLANDS

13.2.11 DENMARK

13.2.12 SWEDEN

13.2.13 POLAND

13.2.14 NORWAY

13.2.15 FINLAND

13.2.16 REST OF EUROPE

13.3 ASIA PACIFIC

13.3.1 JAPAN

13.3.2 CHINA

13.3.3 SOUTH KOREA

13.3.4 INDIA

13.3.5 SINGAPORE

13.3.6 THAILAND

13.3.7 INDONESIA

13.3.8 MALAYSIA

13.3.9 PHILIPPINES

13.3.10 AUSTRALIA

13.3.11 NEW ZEALAND

13.3.12 VIETNAM

13.3.13 TAIWAN

13.3.14 REST OF ASIA-PACIFIC

13.4 SOUTH AMERICA

13.4.1 BRAZIL

13.4.2 ARGENTINA

13.4.3 REST OF SOUTH AMERICA

13.5 MIDDLE EAST AND AFRICA

13.5.1 SOUTH AFRICA

13.5.2 EGYPT

13.5.3 BAHRAIN

13.5.4 UNITED ARAB EMIRATES

13.5.5 KUWAIT

13.5.6 OMAN

13.5.7 QATAR

13.5.8 SAUDI ARABIA

13.5.9 REST OF MEA

13.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

14 GLOBAL OCULAR IMPLANTS MARKET, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: GLOBAL

14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

14.3 COMPANY SHARE ANALYSIS: EUROPE

14.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC

14.5 MERGERS & ACQUISITIONS

14.6 NEW PRODUCT DEVELOPMENT & APPROVALS

14.7 EXPANSIONS

14.8 REGULATORY CHANGES

14.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

15 GLOBAL OCULAR IMPLANTS MARKET, SWOT ANALYSIS

16 GLOBAL OCULAR IMPLANTS MARKET, COMPANY PROFILE

16.1 ALCON, INC.

16.1.1 COMPANY OVERVIEW

16.1.2 REVENUE ANALYSIS

16.1.3 GEOGRAPHIC PRESENCE

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 JOHNSON & JOHNSON VISION

16.2.1 COMPANY OVERVIEW

16.2.2 REVENUE ANALYSIS

16.2.3 GEOGRAPHIC PRESENCE

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 BAUSCH + LOMB

16.3.1 COMPANY OVERVIEW

16.3.2 REVENUE ANALYSIS

16.3.3 GEOGRAPHIC PRESENCE

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 CARL ZEISS AG

16.4.1 COMPANY OVERVIEW

16.4.2 REVENUE ANALYSIS

16.4.3 GEOGRAPHIC PRESENCE

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 STAAR SURGICAL

16.5.1 COMPANY OVERVIEW

16.5.2 REVENUE ANALYSIS

16.5.3 GEOGRAPHIC PRESENCE

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 MORCHER GMBH

16.6.1 COMPANY OVERVIEW

16.6.2 REVENUE ANALYSIS

16.6.3 GEOGRAPHIC PRESENCE

16.6.4 PRODUCT PORTFOLIO

16.6.5 RECENT DEVELOPMENTS

16.7 GLAUKOS CORPORATION

16.7.1 COMPANY OVERVIEW

16.7.2 REVENUE ANALYSIS

16.7.3 GEOGRAPHIC PRESENCE

16.7.4 PRODUCT PORTFOLIO

16.7.5 RECENT DEVELOPMENTS

16.8 SCIENCE CORPORATION

16.8.1 COMPANY OVERVIEW

16.8.2 REVENUE ANALYSIS

16.8.3 GEOGRAPHIC PRESENCE

16.8.4 PRODUCT PORTFOLIO

16.8.5 RECENT DEVELOPMENTS

16.9 CORNEAGEN

16.9.1 COMPANY OVERVIEW

16.9.2 REVENUE ANALYSIS

16.9.3 GEOGRAPHIC PRESENCE

16.9.4 PRODUCT PORTFOLIO

16.9.5 RECENT DEVELOPMENTS

16.1 PRESBIA

16.10.1 COMPANY OVERVIEW

16.10.2 REVENUE ANALYSIS

16.10.3 GEOGRAPHIC PRESENCE

16.10.4 PRODUCT PORTFOLIO

16.10.5 RECENT DEVELOPMENTS

16.11 ALLERGAN (ABBVIE)

16.11.1 COMPANY OVERVIEW

16.11.2 REVENUE ANALYSIS

16.11.3 GEOGRAPHIC PRESENCE

16.11.4 PRODUCT PORTFOLIO

16.11.5 RECENT DEVELOPMENTS

16.12 ADVANCED ARTIFICIAL EYE

16.12.1 COMPANY OVERVIEW

16.12.2 REVENUE ANALYSIS

16.12.3 GEOGRAPHIC PRESENCE

16.12.4 PRODUCT PORTFOLIO

16.12.5 RECENT DEVELOPMENTS

16.13 NATIONAL ARTIFICIAL EYE SERVICES (NHS)

16.13.1 COMPANY OVERVIEW

16.13.2 REVENUE ANALYSIS

16.13.3 GEOGRAPHIC PRESENCE

16.13.4 PRODUCT PORTFOLIO

16.13.5 RECENT DEVELOPMENTS

16.14 MED-EL

16.14.1 COMPANY OVERVIEW

16.14.2 REVENUE ANALYSIS

16.14.3 GEOGRAPHIC PRESENCE

16.14.4 PRODUCT PORTFOLIO

16.14.5 RECENT DEVELOPMENTS

16.15 SANTEN PHARMACEUTICAL

16.15.1 COMPANY OVERVIEW

16.15.2 REVENUE ANALYSIS

16.15.3 GEOGRAPHIC PRESENCE

16.15.4 PRODUCT PORTFOLIO

16.15.5 RECENT DEVELOPMENTS

16.16 NIDEK CO., LTD.

16.16.1 COMPANY OVERVIEW

16.16.2 REVENUE ANALYSIS

16.16.3 GEOGRAPHIC PRESENCE

16.16.4 PRODUCT PORTFOLIO

16.16.5 RECENT DEVELOPMENTS

16.17 HOYA CORPORATION

16.17.1 COMPANY OVERVIEW

16.17.2 REVENUE ANALYSIS

16.17.3 GEOGRAPHIC PRESENCE

16.17.4 PRODUCT PORTFOLIO

16.17.5 RECENT DEVELOPMENTS

16.18 OCULENTIS GMBH

16.18.1 COMPANY OVERVIEW

16.18.2 REVENUE ANALYSIS

16.18.3 GEOGRAPHIC PRESENCE

16.18.4 PRODUCT PORTFOLIO

16.18.5 RECENT DEVELOPMENTS

16.19 RAYNER INTRAOCULAR LENSES LIMITED

16.19.1 COMPANY OVERVIEW

16.19.2 REVENUE ANALYSIS

16.19.3 GEOGRAPHIC PRESENCE

16.19.4 PRODUCT PORTFOLIO

16.19.5 RECENT DEVELOPMENTS

16.2 HUMANOPTICS AG

16.20.1 COMPANY OVERVIEW

16.20.2 REVENUE ANALYSIS

16.20.3 GEOGRAPHIC PRESENCE

16.20.4 PRODUCT PORTFOLIO

16.20.5 RECENT DEVELOPMENTS

16.21 PHYSIOL

16.21.1 COMPANY OVERVIEW

16.21.2 REVENUE ANALYSIS

16.21.3 GEOGRAPHIC PRESENCE

16.21.4 PRODUCT PORTFOLIO

16.21.5 RECENT DEVELOPMENTS

16.22 VSY BIOTECHNOLOGY

16.22.1 COMPANY OVERVIEW

16.22.2 REVENUE ANALYSIS

16.22.3 GEOGRAPHIC PRESENCE

16.22.4 PRODUCT PORTFOLIO

16.22.5 RECENT DEVELOPMENTS

16.23 LENSTEC, INC.

16.23.1 COMPANY OVERVIEW

16.23.2 REVENUE ANALYSIS

16.23.3 GEOGRAPHIC PRESENCE

16.23.4 PRODUCT PORTFOLIO

16.23.5 RECENT DEVELOPMENTS

16.24 BIOTECH HEALTHCARE GROUP

16.24.1 COMPANY OVERVIEW

16.24.2 REVENUE ANALYSIS

16.24.3 GEOGRAPHIC PRESENCE

16.24.4 PRODUCT PORTFOLIO

16.24.5 RECENT DEVELOPMENTS

16.25 EYEKON MEDICAL, INC.

16.25.1 COMPANY OVERVIEW

16.25.2 REVENUE ANALYSIS

16.25.3 GEOGRAPHIC PRESENCE

16.25.4 PRODUCT PORTFOLIO

16.25.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

17 RELATED REPORTS

18 QUESTIONNAIRE

19 ABOUT DATA BRIDGE MARKET RESEARCH

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Type (Intraocular Lenses, Ocular Prosthesis, Glaucoma Implants, Corneal Implants, Orbital implants, Others), Application (Glaucoma Surgery, Ocuplasty, Drug Delivery, Age-Related Macular Degeneration, Aesthetic Purpose, Others), Material (Non-integrated Implants, Integrated Implants), End User (Eye Specialty Clinics, Eye Institutes, Ambulatory surgical centers, Specialty clinics, Hospitals, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028 .
The Global Ocular Implants Market size was valued at USD 8662.29 USD Million in 2020.
The Global Ocular Implants Market is projected to grow at a CAGR of 5.94% during the forecast period of 2021 to 2028.
The major players operating in the market include ,areBausch &amp, Lomb Incorporated, Zeiss International, Johnson &amp, Johnson Private Limited, MORCHER, STAAR SURGICAL, HOYA Corporation, AST ProductsInc., Second Sight, Allergan, Lubrizol Life Science, SMR Ophthalmic Pvt. Ltd., MED-EL Medical Electronics., MeKo Laser Material Processing, NVISION Eye Centers, iSTARMedica Gulden Ophthalmics, Ophtec BV,Aetna Inc., and Care Group, .

Industry Related Reports

Testimonial